Be the first to like this
This report features survey data portraying the perspectives of US physicians (cardiologists, CNS/ neurologists, oncologists, PCP, and respiratory/ pulmonologists) regarding their familiarity and prescription propensity for biosimilar products. This is not ISR’s first report on the views that US physicians hold regarding biosimilars. In comparison to our 2013 Biosimilar Primer report, physician familiarity with biosimilars has increased. With this data, biopharmaceutical companies, payers, and service providers can make more informed decisions regarding product marketing, delivery, and manufacturing.
For more information, visit: http://www.isrreports.com/product/biosimilar-primer-us-physicians-attitudes-beliefs-and-intentions/